Back to results
US 10,238,533 B2Granted
Gastric, cutaneous, or peritoneal delivery of frozen mist to induce therapeutic hyperthermia
AssigneeQool Therapeutics, Inc.
InventorAmir Belson
Life of this patent
Estimating the term…
Abstract
Peritoneal heat exchange provides the benefit of extremely rapid cooling of the patient's target organs such as the heart and brain as well as facilitating global patient body temperature reduction to therapeutically effective temperatures. The heat exchange medium of the present invention is a chilled gaseous fluid suspension of frozen ice particles.
Claims6
A system for cooling a patient, said system comprising:
- a generator configured to produce a cooled, flowing gas stream having entrained frozen solid particles therein;
- an inlet conduit including at least one tubular element having a distal end configured for percutaneous self-insertion through an abdominal wall into a body cavity without damaging internal organs and for directing the cooled, flowing gas stream to a body surface which is not part of the patient's respiratory system, wherein the frozen solid particles are directly exposed to the body surface and melt to absorb body heat to cause at least one of lowering and controlling the patient's body temperature, and
- an outlet conduit including at least one tubular element having a distal end configured for percutaneous self-insertion through the abdominal wall without damaging internal organs and wherein the inlet conduit is separate from the outlet conduit and the conduits are configured to be introduced through spaced-apart opposed locations on the abdominal wall.
Dependencies are inferred from the claim text.